Introduction
============

Amiodarone is a benzofuran class III antiarrhythmic drug used to treat a wide spectrum of ventricular and supraventricular tachyarrhythmias. The mechanism of action is complex. It involves antagonism of the delayed rectifier potassium channels, in particular the rapid component, thereby increasing membrane refractoriness. This agent also affects inactivated sodium channels (Phase 0), sympathetic activity, and calcium channels (L-type).[@b1-dhps-5-191] Long-term therapy is associated with various adverse effects due to accumulation of the drug in tissue. The intravenous (IV) preparation of amiodarone has been linked to adverse hepatic reactions such as hypotension, cardiac arrest, bradycardia, heart failure, and hepatic abnormalities.[@b2-dhps-5-191] We report an unusual case of acute hepatitis immediately after the initiation of IV amiodarone.

Case description
================

An 88-year-old Caucasian female presented to the emergency room complaining of shortness of breath with minimal exertion. This was associated with intermittent heart palpitations and fatigue. Her symptoms had gradually worsened over the prior month in response to family and emotional stress. She denied chest pain, cough, hemoptysis, nausea, vomiting, or diarrhea.

Her past medical history consisted of hypothyroidism, hypertension, and depression. Her only prior surgery was a hysterectomy. A recent echocardiogram revealed a normal ejection fraction with Grade 1 diastolic dysfunction. Family history was unremarkable. She did not use tobacco, alcohol, or illicit drugs. Her home medications included sertraline 25 mg daily, levothyroxine 25 mg daily, and lisinopril 20 mg daily.

A physical examination revealed the following vitals: a blood pressure of 147/52 mmHg, a temperature of 97.6°F, a respiratory rate of 20 breaths/minute, and a heart rate of 130 beats/minute. Cardiac auscultation demonstrated an irregular rhythm with a diastolic murmur heard best at the left upper sternal border, likely to be aortic in origin. An S3 gallop was present, and point of maximal impulse was laterally displaced. Auscultation of the lungs revealed bibasilar rales. Peripheral pulses were strong and equal bilaterally. There was moderate edema present in the lower extremities, and hepatojugular reflux was noted.

Laboratory testing identified the following values: white blood cell count of 8.8 × 10^3^/μL, hemoglobin of 13.1 g/dL, platelet count of 277 × 10^3^/μL, glucose level of 108 mg/dL, creatinine of 61.88 μmol/L, aspartate aminotransferase (AST) of 24 units/L, alanine aminotransferase (ALT) of 16 units/L, bilirubin total of 8.5 μmol/L, alkaline phosphatase of 98 units/L, and thyroid-stimulating hormone of 2.92 μIU/mL. All electrolytes were within normal limits. An initial electrocardiogram (ECG) revealed atrial fibrillation with a rapid ventricular response ([Figure 1](#f1-dhps-5-191){ref-type="fig"}).

Intravenous diltiazem was initiated in order to control the ventricular rate. Shortly after, the patient's rhythm converted to normal sinus rhythm spontaneously. She subsequently developed sinus pauses lasting up to 6 seconds; consequently, diltiazem was discontinued. Until a permanent pacemaker could be inserted, IV amiodarone was commenced in order to maintain sinus rhythm and prevent a rapid ventricular response. Following a loading dose of 150 mg, we administered 360 mg of amiodarone infused at a rate of 1 mg/min over 6 hours, after which a maintenance infusion rate of 0.5 mg/min was continued.

The next day, a routine laboratory evaluation illustrated an acute elevation to the following measurements: AST 1,881 units/L (normal high 35 units/L), ALT 1,048 units/L (normal high 35 units/L), alkaline phosphatase 143 units/L (normal high 129 units/L), total bilirubin 15.3 μmol/L (normal high 17 μmol/L), and creatinine 97.2 μmol/L (normal high 88 μmol/L) ([Table 1](#t1-dhps-5-191){ref-type="table"}). At that point, we reviewed all medications and obtained a hepatitis panel, which was normal. She had been on the same home medications for months without any change. A hepatic ultrasound identified venous congestion. We suspected amiodarone as a cause; thus, it was discontinued after administering a total dose of 960 mg over a 10-hour period. Signs of a hypersensitivity reaction such as itching, rash, or eosinophilia were not seen. Liver transaminases returned to baseline within 7 days. Further investigation with a cardiac echocardiogram demonstrated a left ventricular ejection fraction (LVEF) of 35%. Subsequently, a left heart catheterization revealed significant coronary artery disease with no clear revascularization targets, and a LVEF of 30%. She then received a permanent pacemaker, made an uneventful recovery, and was discharged on carvedilol, lisinopril, warfarin, and levothyroxine. Over the next 12 weeks, the patient suffered from progressive heart failure, which was managed both in the office and at home. Eventually, she died of advanced pump failure with progressive edema and respiratory failure.

Discussion
==========

Major side effects of oral amiodarone are related to drug accumulation in tissue when given over a long period of time. Adverse reactions include thyroid dysfunction, sinus bradycardia, ventricular arrhythmias, and pulmonary and hepatic toxicity. Approximately 25% of patients taking this medication develop a transient asymptomatic rise in serum aminotransferase levels. Symptomatic hepatitis, cirrhosis, and hepatic failure are rare complications which involve less than 3% of patients.[@b3-dhps-5-191],[@b4-dhps-5-191] Histological features of oral amiodarone hepatitis are similar to alcoholic hepatitis and include steatosis, fibrosis, and phospholipid laden lysosomal lamellar bodies. The CIOMS/RUCAM scale identifies our patient's acute hepatitis as a highly probable adverse drug reaction.[@b5-dhps-5-191] There was a mild total bilirubin elevation to 0.9 mg/dL; therefore, this case of drug-induced liver injury (DILI) did not meet Hy's Law criteria, which states that hepatocellular injury accompanied by a total bilirubin elevation over twice the upper limit of normal is of significant concern and has a mortality of 10%--15%.[@b6-dhps-5-191]

Intravenous amiodarone is typically used as a short-term therapy for various arrhythmias (as mentioned previously). It is metabolized to N-desethylamiodarone (DEA) by cytochrome P450 enzymes (CYP3A4 and CYP2C8). Its metabolite is also an antiarrhythmic. Amiodarone is primarily eliminated by biliary excretion. Left ventricular dysfunction prolongs the half-life of DEA. Acute hepatitis, due to parenteral therapy, is extremely rare.[@b7-dhps-5-191] Our literature review identified 33 previously reported cases. The underlying mechanism is controversial and still unknown. Ischemic hepatitis, a much more common condition, shares many clinical and histological characteristics that are seen in parenteral amiodarone-induced liver injury. It has been hypothesized by Gluck et al that the acute liver injury following the IV formulation is related to liver ischemia, rather than direct drug toxicity.[@b8-dhps-5-191] This was based on the observation that the two conditions show similar histological features and clinical events. Furthermore, DILI caused by oral and IV amiodarone demonstrate different histologic findings. The majority of patients receiving the IV form are suffering from unstable tachyarrhythmias, which may result in a decreased cardiac output, hypotension, and ischemia. Most patients described in the reviewed cases had evidence of poor forward output, hepatic venous congestion, impaired circulation and acute kidney injury, predisposing them to ischemic hepatitis. Finally, another report by Lahbabi et al ascribes responsibility of liver toxicity to solubilizers such as polysorbate 80 in the IV amiodarone preparation.[@b9-dhps-5-191] Polysorbate 80 has been implicated in the E-Ferol syndrome characterized by renal failure, hepatosplenomegaly, and jaundice. Eliminating polysorbate 80 by the oral route demonstrated the safe use of amiodarone even after acute hepatitis in several studies.

Our patient showed evidence of impaired left ventricular function with an LVEF of 30% by ECG (decreased from 50% one month prior to admission). Also, there was evidence of acute elevation of her creatinine from 0.7 to 1.1 mg/dL, suggestive of a degree of hypoperfusion. Hepatojugular reflux was elicited and central venous pressure was elevated subsequent to liver injury. The causal correlation is not clear as to which condition (cardio--renal dysfunction or liver failure) induced the other. We believe that in susceptible elderly patients, even the standard intravenous amiodarone dose may cause direct drug toxicity and hypotension, especially in the setting of heart failure, leading to hepatic injury.

Further research is needed to support a true acute amiodarone hepatotoxicity versus other proposed or even unknown mechanisms ([Figure 2](#f2-dhps-5-191){ref-type="fig"}). Six fatal cases of IV amiodarone hepatitis have been reported, suggesting the severity of this condition ([Table 2](#t2-dhps-5-191){ref-type="table"}).[@b10-dhps-5-191]--[@b34-dhps-5-191] Elevation of transaminases occurred within 24 hours of drug administration in most patients. The majority of these cases were associated with some degree of cardiac dysfunction and renal failure. Our case was fatal in 12 weeks due to progressive pump failure, and the DILI event may have been a harbinger of mortality. The mechanism of progressive left ventricular failure may have been secondary to the impact of systemic inflammation, neurohormonal stress, and microcirculatory dysfunction caused in part by the acute organ failure of the liver ([Figure 3](#f3-dhps-5-191){ref-type="fig"}). We believed persistent hepatic venous congestion played a role and may have been a determinant. This case suggests that one should regularly obtain a liver function panel subsequent to parenteral amiodarone initiation and proceed with caution in the setting of heart failure and hepatic congestion.

Conclusion
==========

Amiodarone is often used to treat life-threatening arrhythmias in the setting of acutely decompensated heart failure. In the presence of hepatic congestion, the IV preparation of amiodarone may cause acute liver injury, which can be a harbinger for a fatal outcome in the days to months after administration. Future research is needed to understand the mechanisms by which hyperacute drug toxicity occurs in the setting of impaired hepatic perfusion and venous congestion.
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![Standard 12-lead electrocardiogram demonstrating atrial fibrillation with rapid ventricular response.](dhps-5-191Fig1){#f1-dhps-5-191}

![Pattern of hepatocyte injury with oral amiodarone, intravenous amiodarone, and hepatic hypoperfusion.\
**Notes:** Intravenous amiodarone is thought to have direct cell toxicity with free radical formation and impairment of mitochondrial function, which leads to centrilobular necrosis.\
**Abbreviation:** Amio, amiodarone; HO, hydroxyl radical.](dhps-5-191Fig2){#f2-dhps-5-191}

![Schematic representation of multiorgan failure contributing to systemic inflammation, oxidative stress, and apoptosis, which contributes to progressive pump failure and death.\
**Abbreviations:** ALT, alanine aminotransferase; AST, aspartate aminotransferase; O~2~, Oxygen; CO~2~, carbon dioxide.](dhps-5-191Fig3){#f3-dhps-5-191}

###### 

Liver--enzyme measurements

  Day of hospitalization   AST (U/L)   ALT (U/L)   Alk Phos (U/L)
  ------------------------ ----------- ----------- ----------------
  Day 1                    24          16          98
   Amio started                                    
  Day 2                    1,881       1,048       143
   Amio discontinued                               
  Day 3                    613         678         155
  Day 4                    328         578         174
  Day 5                    221         470         160
  Day 6                    161         339         129

**Abbreviations:** Alk Phos, alkaline phosphatase; ALT, alanine aminotransferase; Amio, amiodarone; AST, aspartate aminotransferase.

###### 

Published cases of fatal intravenous amiodarone-induced acute hepatitis

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Year   Authors                               Age   Sex   Indication                        Associated conditions                    AST/ALT (×ULN)   ALK PHOS/BILI (×ULN)   Creatinine (μmol/L)   Latency period   Cumulative amio dose (mg)   Oral rechallenge test                       Fatality
  ------ ------------------------------------- ----- ----- --------------------------------- ---------------------------------------- ---------------- ---------------------- --------------------- ---------------- --------------------------- ------------------------------------------- ------------------------------------------------------
  1986   Lupon-Roses et al[@b11-dhps-5-191]    77    M     Atrial tachycardia                Jaundice                                 AST: 47\         BILI: 5                --                    3 days           2,300                       --                                          --
                                                                                                                                      ALT: 29                                                                                                                                                

  1988   Pye et al[@b12-dhps-5-191]            48    F     Atrial fibrillation               MR (moderate)                            AST: 47\         BILI: 7                --                    1 day            1,200                       Negative test                               --
                                                                                                                                      ALT: 32                                                                                                                                                

  1988   Pye et al[@b12-dhps-5-191]            70    F     Atrial fibrillation               HF, MI, MR, PH                           AST: 60\         BILI: 3                --                    7 days           8,700                       --                                          --
                                                                                                                                      ALT: 26                                                                                                                                                

  1989   Stevenson et al[@b13-dhps-5-191]      59    M     Atrial fibrillation               HF, hepatomegaly, jaundice               AST: 10          ALK PHOS: 2\           --                    1 day            450                         --                                          --
                                                                                                                                                       BILI: 17                                                                                                                              

  1990   Simon et al[@b14-dhps-5-191]          59    M     Atrial fibrillation               Pulmonary edema                          AST: 37\         BILI: Nrml             --                    1 day            1,200                       Positive test with intravenous amiodarone   --
                                                                                                                                      ALT: 38                                                                                                                                                

  1991   MorelIi et al[@b15-dhps-5-191]        58    M     Atrial fibrillation               Jaundice, nausea                         AST: 15\         ALK PHOS: 5\           --                    3 days           3,070                       Negative test                               --
                                                                                                                                      ALT: 5           BILI: 3                                                                                                                               

  1991   MorelIi et al[@b15-dhps-5-191]        68    M     Ventricular fibrillation          Hepatomegaly, edema, HF                  AST: 4\          ALK PHOS: 5\           --                    6 days           2,375                       Negative test                               --
                                                                                                                                      ALT: 2           BILI: 3                                                                                                                               

  1991   Kalantzis et al[@b16-dhps-5-191]      28    M     Atrial fibrillation               Jaundice, hepatomegaly, renal failure    AST: 501\        BILI: 6                963-required HD       1 day            1,500                       --                                          Died after 14 days of hepatorenal failure and coma
                                                                                                                                      ALT: 370                                                                                                                                               

  1991   Kalantzis et al[@b16-dhps-5-191]      60    M     Atrial fibrillation               Hepatomegaly, renal failure              AST: 30\         BILI: 5                274                   1 day            1,500                       --                                          Died after 4 days of hepatic coma and renal failure
                                                                                                                                      ALT: 10                                                                                                                                                

  1992   Fornaciari et al[@b17-dhps-5-191]     52    F     Ventricular tachycardia           Hepatomegaly                             AST: 50\         BILI: 29               --                    36 hours         1,200                       --                                          --
                                                                                                                                      ALT: 45                                                                                                                                                

  1993   Rhodes et al[@b18-dhps-5-191]         72    M     Ventricular tachycardia           Oliguria, hepatic encephalopathy         AST: 131\        BILI: 3                328                   12 hours         1,200                       Negative test                               --
                                                                                                                                      ALT: 132                                                                                                                                               

  1995   Tosetti et al[@b19-dhps-5-191]        66    M     Atrial fibrillation               Nausea, oliguria                         AST: 9\          ALK PHOS: 1.3          --                    1 day            400                         --                                          --
                                                                                                                                      ALT: 11                                                                                                                                                

  1996   Paniagua et al[@b20-dhps-5-191]       80    F     Atrial fibrillation               Hepatomegaly                             AST: 82\         --                     254                   1 day            750                         --                                          --
                                                                                                                                      ALT: 59                                                                                                                                                

  1997   James et al[@b21-dhps-5-191]          50    M     Atrial fibrillation               Dyspnea                                  AST: 205         --                     --                    1 day            1,200                       Negative test                               --

  1997   Tagliamonte et al[@b22-dhps-5-191]    61    M     Ventricular tachycardia           Jaundice                                 AST: 243\        ALK PHOS: 2.5\         --                    1 day            --                          --                                          --
                                                                                                                                      ALT: 122         BILI: 10                                                                                                                              

  1998   Breuer et al[@b23-dhps-5-191]         64    M     Atrial fibrillation               HF, renal failure, anemia, hypotension   AST: 63\         --                     --                    4 days           3,400                       --                                          --
                                                                                                                                      ALT: 69                                                                                                                                                

  1999   Iliopoulou et al[@b24-dhps-5-191]     69    M     Premature ventricular complexes   Angina                                   AST: 50\         BILI: increased        --                    1 day            1,500                       --                                          --
                                                                                                                                      ALT: 50                                                                                                                                                

  1999   Lopez-Gamez et al[@b25-dhps-5-191]    60    M     Ventricular tachycardia           Jaundice                                 ALT: 57          BILI: 8                --                    7 days           2,400                       Negative test                               --

  2000   Luengo et al[@b26-dhps-5-191]         68    F     Atrial fibrillation               Hepatomegaly                             AST: 14\         --                     --                    5 days           1,300                       --                                          --
                                                                                                                                      ALT: 37                                                                                                                                                

  2002   Gregory et al[@b28-dhps-5-191]        74    F     Ventricular tachycardia           Dyspnea                                  AST: 13\         --                     --                    1 day            1,740                       Negative test                               --
                                                                                                                                      ALT: 8                                                                                                                                                 

  2002   Gonzalez et al[@b27-dhps-5-191]       69    F     Atrial fibrillation               Jaundice                                 AST: 195\        BILI: 4                --                    1 day            1,200                       --                                          --
                                                                                                                                      ALT: 227                                                                                                                                               

  2002   Agozzino et al[@b29-dhps-5-191]       83    F     Atrial fibrillation               HF, oliguria                             AST: 365\        BILI: 19               300                   1 day            1,000                       --                                          --
                                                                                                                                      ALT: 135                                                                                                                                               

  2002   Giannattasio et al[@b30-dhps-5-191]   65    M     Supraventricular tachycardia      Jaundice, hepatomegaly, edema            ALT: 100         BILI: 4                --                    1 day            600                         --                                          --

  2002   Giannattasio et al[@b30-dhps-5-191]   55    M     Atrial fibrillation               Core pulmonaly, hepatomegaly             ALT: 10          --                     --                    3 days           600                         Negative test                               

  2002   Giannattasio et al[@b30-dhps-5-191]   75    F     Supraventricular tachycardia      Jaundice, ascites                        ALT: 60          BILI: 19               --                    1 day            600                         --                                          Died after 31 days of hepatic failure

  2005   Rätz Bravo et al[@b31-dhps-5-191]     66    F     Atrial fibrillation               HF, postop                               AST: 106\        ALK PHOS: Nrml\        --                    1 day            200                         --                                          --
                                                                                                                                      ALT: 66          BILI: Nrml                                                                                                                            

  2005   Rätz Bravo et al[@b31-dhps-5-191]     73    F     Atrial fibrillation               Postop, no hypotension                   AST: 485\        ALK PHOS: 2\           --                    14 hours         720                         --                                          --
                                                                                                                                      ALT: 206         BILI: Nrml                                                                                                                            

  2005   Rätz Bravo et al[@b31-dhps-5-191]     57    M     Atrial fibrillation               HF, post CABG, low MAP during surgery    AST: 44\         ALK PHOS; Nrml\        --                    1 day            890                         --                                          --
                                                                                                                                      ALT: 51          BILI: 2                                                                                                                               

  2008   Chan et al[@b34-dhps-5-191]           72    F     Atrial fibrillation               Hypotension, jaundice, oliguria          AST: 33\         ALK PHOS: 1.5\         274                   1 day            2,550                       --                                          Died after 20 days of hepatic coma and renal failure
                                                                                                                                      ALT: 42          BILI: 1.1                                                                                                                             

  2008   Cataldi et al[@b32-dhps-5-191]        77    F     Atrial fibrillation               HF, fluid overload                       AST: 53\         BILI: 2                --                    1 day            750                         --                                          Died after 29 days of multiorgan failure
                                                                                                                                      ALT: 40                                                                                                                                                

  2009   Murphy et al[@b10-dhps-5-191]         59    M     Atrial fibrillation               LVH                                      AST: 172\        ALK PHOS: 1.5\         236                   1 day            1,200                                                                   Died after 4 days of acute hepatic failure
                                                                                                                                      ALT: 83          BILI: 68                                                                                                                              

  2012   Lahbabi et al[@b9-dhps-5-191]         29    F     Atrial fibrillation               Severe MR, LV dilation                   ALT: 19          ALK PHOS: Nrml\        70                    1 day            1,599                       Negative test                               --
                                                                                                                                                       BILI: Nrml                                                                                                                            

  2012   Grecian et al[@b33-dhps-5-191]        73    M     Ventricular tachycardia           Hx of HF, fulminant hepatic failure      ALT: 44          BILI: 5                274                   1 day            900                         --                                          --
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

**Abbreviations:** ALK, alkaline; PHOS, phosphatase; BILI, bilirubin total; AST, aspartate aminotransferase; ALT, alanine aminotransferase; HF, heart failure; MR, mitral regurgitation; PH, pulmonary hypertension; MAP, mean arterial pressure; CABG, coronary artery bypass grafting; MI, myocardial infarction; HD, hemodialysis; Nrml, normal; Amio, amiodarone; LVH, left ventricular hypertrophy; ULN, upper limit of normal; Hx, history; LV, left ventricle.
